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Abstract
Mitochondrial dynamics are dependent on both the microtubule and actin cytoskeletal systems.
Evidence for the involvement of myosin motors has been described in many systems, and until
recently a candidate mitochondrial transport motor had not been described in vertebrates. Myosin-
XIX (MYO19) was predicted to represent a novel class of myosin and had previously been shown
to bind to mitochondria and increase mitochondrial network dynamics when ectopically
expressed. Our analyses comparing ∼40 MYO19 orthologs to ∼2000 other myosin motor domain
sequences identified instances of homology well-conserved within class XIX myosins that were
not found in other myosin classes, suggesting MYO19-specific mechanochemistry. Steady-state
biochemical analyses of the MYO19 motor domain indicate that Homo sapiens MYO19 is a
functional motor. Insect cell-expressed constructs bound calmodulin as a light chain at the
predicted stoichiometry and displayed actin-activated ATPase activity. MYO19 constructs
demonstrated high actin affinity in the presence of ATP in actin-cosedimentation assays, and
translocated actin filaments in gliding assays. Expression of GFP-MYO19 containing a mutation
impairing ATPase activity did not enhance mitochondrial network dynamics, as occurs with wild-
type MYO19, indicating that myosin motor activity is required for mitochondrial motility. The
measured biochemical properties of MYO19 suggest it is a high-duty ratio motor that could serve
to transport mitochondria or anchor mitochondria, depending upon the cellular microenvironment.
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Introduction
Like many intracellular components, mitochondria undergo dynamic organization mediated
through the cytoskeleton. These essential organelles play a central role in metabolism,
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participate in calcium signaling, and are also involved in apoptotic processes. Mitochondrial
membrane fission [De Vos et al., 2005; Korobova et al., 2013], mtDNA copy number
[Reyes et al., 2011], and intracellular position [Boldogh et al., 2001; Minin et al., 2006] have
been shown to require cytoskeletal elements in a variety of systems. A recent study by
DuBoff et al. [DuBoff et al., 2012] demonstrated a linkage between the actin and
microtubule cytoskeleton in mitochondrial fission in neurons. Additionally, long-distance
mitochondrial movement is dependent on microtubule-based motors [Hollenbeck and
Saxton, 2005; Morris and Hollenbeck, 1995] whereas short-range movement and docking of
mitochondria is achieved via the actin cytoskeleton [Chada and Hollenbeck, 2004; Pathak et
al., 2010; Quintero et al., 2009].
Mechanisms for regulating mitochondrial positioning via the actin cytoskeleton vary
[Boldogh and Pon 2006]. In yeast, the class V myosin motor, Myo2p, and its light chain,
Mlc1p, have been shown to play a direct role in mitochondrial motility and inheritance
[Altmann et al., 2008]. C. elegans ANC-1 contains an actin binding domain and a nuclear
envelope localization domain; mutations in anc-1 disrupt the positioning and the shape of
mitochondria [Starr and Han, 2002]. In Drosophila neuronal cells myosin V and VI have
been reported to oppose long range microtubule-based movements and facilitate docking of
the organelle [Pathak et al., 2010]. In mammalian cell culture, myosin XIX (MYO19) has
been shown to play a role in mitochondrial positioning [Quintero et al., 2009].
Although well characterized for their roles as molecular motors, some actomyosin systems
are involved in other processes besides transport. Class I myosins bind cellular membranes
and have been shown to be involved in the formation of membrane compartments at the
plasma membrane as well as the fusion of compartments to the plasma membrane (reviewed
in [McConnell and Tyska 2010]). Other roles include the establishing and maintaining
membrane tension in a variety of cellular structures [Self et al., 1998; Self et al., 1999;
Tyska et al. 2005]. Myosin-membrane interactions underlie long-term potentiation and long
term depression, where interactions between class V myosins and the endoplasmic reticulum
establish the receptor-content within a dendritic spine, thereby modulating the strength and
sensitivity of the synapse [Dekker-Ohno et al., 1996; Lisé et al., 2006; Miyata et al., 2000;
Wang et al., 2008].
All myosins have a common actin-activated ATPase motor domain which generates force
through conformational changes coupled to biochemical transitions of the ATPase cycle.
This motor domain has structural and sequence homology that is conserved throughout the
myosin family. However, analysis of the kinetics, structure, and function of different
myosins suggest that despite having a common core motor domain, each myosin has
differences that tune its chemomechanical activity for specific physiological functions [De
La Cruz and Ostap, 2004]. This tuning can be observed as differences in enzymatic and
biophysical properties across myosin classes. Specific differences in the amino acid
sequence ultimately impact both structure and function [reviewed in Cope et al., 1996;
Mooseker and Foth, 2008].
Therefore, insight into the function of uncharacterized myosins can come from comparison
to the well-characterized myosins which have known amino acid sequences, structures, and
enzymatic properties. The number of available myosin sequences has increased as a result of
many large-scale genome sequencing projects, as has the available structural data, and
kinetic data. We can now begin to approach the characterization of unknown myosins
through a combination of both informatic and experimental approaches.
MYO19 is a novel unconventional myosin which colocalizes with mitochondria and may
play an important role in mitochondrial positioning [Quintero et al., 2009]. The aim of this
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study was to employ comparative and experimental approaches to further our understanding
of the chemomechanical activity of MYO19 by identifying class XIX-specific differences
conserved across MYO19 orthologs, and determining the steady-state enzymatic
characteristics of the human MYO19 motor domain. Understanding the unique structural
components and kinetics of MYO19 will give us insight into its cellular and biological
function. Our results indicate that MYO19 is indeed an actin-activated ATPase with the
ability to power the translocation of actin filaments in vitro, and that motor ATPase activity
is required for transporting mitochondria within cells.
Results and Discussion
Sequence analysis reveals conserved variation within class XIX myosins
As reported previously, the human MYO19 gene encodes for a 970 amino acid protein
consisting of a motor domain, neck region containing 3 IQ-motifs, and a MYO19-specific
mitochondria outer membrane association (MyMOMA) domain [Quintero et al., 2009].
Comparison of alignments of MYO19 orthologs (Figure 1A, Supplemental Figure 1),
alignments of human MYO19 to other myosin classes (Supplemental Figure 2), and
structural predictions via threading [Combet et al., 2002; Kelley and Sternberg, 2009] allow
for the identification of sequences conserved within the core motor domain of MYO19
(Supplemental Figure 3). Analysis of these conserved regions revealed class-specific
differences in the core sequences, as well as class-specific insertions that do not appear in
other myosins.
The myosin motor contains a Walker-A ATPase domain composed of residues that
coordinate ATP and Mg2+ in the active site. Catalytic residues mediate the hydrolysis of the
β-γ phosphate bond which is followed by release of hydrolysis products. Nucleotide state is
communicated to the actin binding region and the lever arm [Cope et al., 1996; Holmes,
2008]. The human MYO19 motor domain contains conserved motifs responsible for
coordinating the phosphates of the ATP—GESGAGKT of the P-loop (132-139),
NNNSSRFGK of switch I (190-198), and D414 of switch II [Fisher et al., 1995]. Other
residues proposed to be involved in phosphate coordination, N76 and E221, are also well
conserved across all MYO19 orthologs examined [Fisher et al., 1995]. Class XIX myosins
contain a class-specific amino acid difference following the P-loop (Figure 1B). In 44 out of
45 MYO19 orthologs analyzed the residue following the P-loop is W, with Daphnia being
the only exception (a cysteine). In the majority the approximately 2000 myosin sequences
available in the alignments by Cope et al. [Cope et al. 1996] and Odrontiz et al. [Odronitz
and Kollmar, 2007], the most common residue following the P-loop is either V or E. The
much bulkier W is only found in class XIX orthologs within the set of sequences available at
the time. This class-specific amino acid change immediately following the P-loop to a larger
side chain might play a role in the affinity for nucleotide in the binding pocket, as threaded
models of MYO19 suggest that W140 is positioned very close to the nucleotide binding site.
It is also interesting to note that in kinesins this position is most often a Y, H, or F [Greene,
et al., 2005] (The kinesin homepage, 2005), which also contain large side chains. The loop
connecting the 25kD and 50kD subdomains of myosin, Loop 1, is part of a helix-loop-helix
that spans the distance between the P-loop and switch I, straddling the nucleotide pocket
[reviewed in Holmes, 2008]. Loop 1 varies in length between myosins, and this region of
MYO19 is well conserved in both sequence and length among vertebrate orthologs. It is
slightly shorter in length than longer Loop 1 regions such as those from MYH2 and
MYO10, and longer in length than Loop 1 of MYO1C, MYO5A, and MYO6 (Figure 1B).
Loop 1 appears to be involved in ADP release [Kurzawa-Goertz et al. 1998; Murphy and
Spudich, 1998]. Switch I and Switch II are regions responsible for communicating
nucleotide state to other regions of the molecule through interactions with the γ-phosphate
of ATP [Smith and Rayment, 1996]. The sequence leading up to and including switch I
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(179-198) is well conserved within MYO19 with some variability at position 191 (NxN)
between species. In other myosins, the amino acid 4 residues prior to the NxN sequence is
most often K. However, this is not the case in MYO19. In 39/45 orthologs this residue (186)
is a cysteine, an amino acid difference found also in class IIIA and IIIB myosins as well as
some insect class IC myosins. Switch II is extremely well conserved within class XIX
myosins and varies little between myosin classes.
The converter region of myosins translates small conformational changes accompanying
hydrolysis product release to large-scale movements of the long α-helix that makes up the
lever arm. Although there is significant sequence variability within the converter region,
there is not a great deal of diversity in length of converter regions, with a few notable
exceptions. In most myosin sequences in the Cope alignment [Cope et al., 1996], the
distance from strand 3 in β–sheet B (RCIxPN) to the conserved lysine in strand 3 in β–sheet
F (TKxF) is approximately 60 amino acids. Additionally, the distance from the conserved
lysine in beta sheet F to the beginning of the first IQ motif in the lever arm is 26 residues.
Class VI myosins contain an insertion of approximately 38 amino acids between beta sheet
F and the lever arm that reorients the lever arm relative to the core motor domain, resulting
in a motor directed towards the actin minus-end [Menetrey et al., 2005]. Multiple sequence
alignment of MYO19 with other myosins revealed a 30-35 amino acid insertion within the
converter domain. Unlike MYO6, this insertion is not between the converter and the lever
arm, and does not align with the MYO6 “reverse gear” (Figure 1C), suggesting that this
sequence may serve a different function than the MYO6 “reverse gear.” It is interesting to
note that the MYO19 insertion in the converter domain cannot be modeled onto existing
myosin structures. The insertion is well-conserved within class XIX myosins, and
comparison to the alignment by Odronitz and Kollmar. [Odronitz and Kollmar, 2007]
reveals that other non-vertebrate classes (24B, 25, 26, 27) also contain insertions of greater
than 10 amino acids within the converter domain.
The actin binding region of myosin consists of a number of loops and subdomains situated
on both sides of a cleft, which is thought to close to facilitate strong binding of actin
[reviewed in Holmes, 2008]. The binding of myosin to actin is partially dependent on
electrostatic interactions between the two molecules. There are well-conserved regions in
the actin binding domain of class XIX orthologs, particularly charged residues (Table I). Our
analyses indicate that there are significant differences in the overall charge of the actin-
interacting regions of MYO19 as compared to other myosins (Figure 2). Specifically, the
Loop 2 region of MYO19 carries no net charge while it is positively charged in the other
sequences to which it was compared. Loop 4 is more negatively charged than comparable
regions in other myosins, while the HCM loop and the helix-turn-helix are more positively
charged than in other myosins (Figure 2). Many of these regions are poorly resolved in
available crystal structures of myosin, but have been modeled through a combination of
cryo-electron microscopy, molecular dynamics, and other structural methods [Holmes et al.,
2004; Lorenz and Holmes, 2010]. Threading of the human MYO19 sequence onto the
modeled structure from Lorenz and Holmes [Lorenz and Holmes, 2010] reveals some
conservation and some differences in the residues implicated in electrostatic interactions and
hydrogen bonds between MYO19 and MYH2 (Figure 2). The positions of the changed
resides in the MYO19 actin-binding region could play a role in the affinity of MYO19 for
actin as well as in the ATPase activity. It has been reported that phosphorylation and
mutations of residues in the actin binding loops alter the ATPase cycle kinetics. Heavy chain
phosphorylation of some class I myosins occurs at the TEDS site in the hypertrophic
cardiomyopathy loop [Bement and Mooseker, 1995]. Phosphorylation of MYO1C lead to
increased ATPase activity by >20 fold but did not significantly affect the affinity of myosin
for actin [Ostap et al., 2002]. Mutagenesis of a single charged residue in Loop 4 of smooth
muscle myosin altered actomyosin affinity and doubled myosin in vitro motility velocity
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[Ajtai et al., 2004]. In these instances, changes to the actin binding region that altered net
charge impacted the mechanochemistry of the motor. Thus, the unique structural elements
and amino acid charge composition in the actin binding region of MYO19 could play a
critical role in defining its enzymatic and biochemical properties.
Expressed and purified MYO19 binds calmodulin via its IQ motifs
We coexpressed two versions of N-terminal FLAG-tagged human MYO19 with calmodulin
in the baculovirus insect cell Sf9 system. MYO19-1IQ contains the motor domain and one
IQ motif. MYO19-3IQ contains the motor domain followed by the lever arm consisting of
three IQ motifs, the amino acid sequence used to generate an α-MYO19 antibody [Quintero
et al., 2009], and a C-terminal 6x-His tag. Yields were approximately 0.15-0.5mg/L of Sf9
cells. The purity of MYO19 following FLAG affinity chromatography was ∼90-95% as
determined by Coomassie staining of SDS-PAGE gels (Figure 3). Both the MYO19-1IQ and
MYO19-3IQ constructs bound and co-purified with calmodulin at the expected
stoichiometries of 1.1±0.1 CaM/MYO19-1IQ (n=3 preparations) and 3.3±0.4 CaM/
MYO19-3IQ (n=3 preparations). Furthermore, we obtained similar values by determining
the amount of calmodulin bound to MYO19-3IQ after actin co-sedimentation (4.1±1.1 CaM/
MYO19-3IQ ratio), and comparing the bound calmodulin to a standard curve of calmodulin
in Coomassie stained SDS-PAGE gels. Experiments using purified MYO19 constructs in
vitro were performed in KMg50DTT (50mM KCl, 10mM imidazole, 1mM EGTA, 1mM
MgCl2, 1mM DTT, pH 7.0) in the presence of 10μM calmodulin to ensure full occupancy of
the IQ motifs. It has yet to be determined if proteins other than CaM serve as endogenous
light chains of MYO19.
MYO19 encodes for an actin-activated ATPase
A hallmark of myosin motors is an actin-activated ATPase activity, and we chose to
characterize this activity for MYO19 using the NADH-coupled assay [De La Cruz and
Ostap, 2009; De La Cruz et al., 2000]. We measured the ATPase activity as a function of
increasing concentrations of phalloidin-stabilized actin, in the presence of 1mM ATP and an
ATP-regenerating system. With no actin present, the rate of ATPase activity for
MYO19-1IQ (ν0) was determined to be 0.03±0.01 s-1 (n=4 preparations). The maximal rate
of actin-activated ATPase activity (kcat) was calculated to be 2.2±0.2 s-1, and the actin
concentration at which ATPase activity was one-half of the maximal activity (KATPase) was
found to be 20.1±3.7 μM (Figure 4A). Very similar results were observed for the
MYO19-3IQ; ν0 was found to be 0.03±0.01s-1 (n=3 preparations), kcat found to be 2.7±0.2
s-1, and KATPase found to be 26.5±5.4μM (Figure 4B). The intrinsic ATPase rate of
MYO19-1IQ was verified through experiments with N-methylanthraniloyl-2′-deoxy-ATP
(MANT-dATP). The fluorescence of MANT-dATP is enhanced upon binding to the active
site of myosins, and decreases upon MANT-dADP dissociation. By mixing 0.25μM MANT-
dATP at with 0.5μM MYO19-1IQ and fitting the observed fluorescence decrease to a single
exponential decay, the intrinsic ATPase activity of MYO19-1IQ was estimated to be
0.03±0.01 s-1, which is in agreement with the value as measured by the NADH-coupled
assay (Figure 4C).
MYO19 steady-state kinetics show an actin-activated ATPase activity that is neither the
slowest nor the fastest among the myosin family, and low to medium concentrations of actin
are required to fully activate the ATPase. Other characterized motors with similar rates of
actin activated ATPase include human MYO1C [El Mezgueldi et al. 2002], chicken smooth
muscle myosin [Cremo and Geeves, 1998; Marston and Taylor, 1980; Rosenfeld et al.,
2000], MYO3A [Dose et al., 2007], Drosophila MYO7A [Yang et al. 2006], mouse
MYO7B [Henn and De La Cruz, 2005] and bovine MYO10 [Kovacs et al., 2005]. However,
some of these myosins differ from MYO19 when comparing the KATPase value. For human
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MYO1C, Drosophila MYO7A, and mouse MYO7B, the KATPase is an order of magnitude
lower than that of MYO19.
MYO19 populates high actin affinity states in the presence of ATP
Determination of the fraction of MYO19 bound to actin is an indication of the fraction of
MYO19 that is populating actin-bound states under steady-state conditions. We performed
MYO19 cosedimentation assays with increasing concentrations of phalloidin-stabilized actin
in the presence of 2mM ATP and an ATP regenerating system. We then measured the
fraction of MYO19-1IQ that was associated with the actin pellet (Figure 4D). The maximum
fraction bound was measured to be 0.77±0.03 (n=3 preparations). These data were fit to a
hyperbola to determine the steady-state actin affinity, Kactin =1.2±0.2μM. A rigor-bound
control sample was run as well (5μM actin, no ATP, no regenerating system), and the
fraction of actin-bound MYO19-1IQ found to be 0.80±0.01. To account for the possibility of
ADP accumulation during the assay, we repeated the experiments eliminating the 10-minute
room temperature incubation in the presence of ATP, and measured ADP levels in the
supernatant at the end of the experiment using the NADH-linked assay. When the 10-minute
prespin incubation with ATP was not included in the assay, the values were similar
(maximum fraction bound = 0.94±0.05 and Kactin = 3.0±0.6μM). ADP levels were
approximately 0.2mM in the supernatants at the end of the assay, which is less than 10% of
the initial ATP concentration.
Cosedimentation assays reveal that MYO19 populates high actin affinity states in the
presence of ATP, suggesting that it has an intermediate to high duty ratio. Alternatively,
MYO19 may contain a high affinity for actin in the “traditional” weakly bound states. Other
myosins that also populate high affinity states in the presence of ATP include MYO5 [De La
Cruz et al., 1999; Yengo et al. 2002] and MYO3A [Dose et al., 2007]. The observed affinity
of MYO19 for actin in the steady-state may be due to the amino acid differences in the
putative actin-binding interface revealed by our sequence analysis. Alternatively, MYO19
may have a high affinity for ADP, which results in the actomyosin·ADP state predominantly
being populated in the cosedimentation assay. Nevertheless, the results suggest that under
near physiological conditions MYO19 contains a relatively high steady-state affinity for
actin.
Interestingly, MYO19 contains a KActin that is 10-fold lower than the KATPase measured in
the steady-state ATPase assays. This property was also observed in MYO9B [Nalavadi et
al., 2005], which is a monomeric myosin that contains a large insert in the actin binding
region. When this large insert in Loop 2 was removed from MYO9B, its actin affinity was
significantly reduced. Loop 2 is known to contribute to actin affinity in the weak binding
states through charge interactions [Joel et al., 2003; Yengo and Sweeney, 2004]. MYO19
also contains a divergent Loop 2 sequence. Rather than containing a large insertion, Loop 2
of MYO19 lacks positive charge. Therefore, the highly positively charged HCM loop and
helix-turn-helix may play roles in enhancing the steady-state actin affinity of MYO19, as
compared to other myosins.
MYO19-3IQ catalyzes translocation of actin filaments, in vitro
The velocity of MYO19-mediated movements were measured in vitro using the actin gliding
filament assay in the presence of an ATP regeneration system, at a range of ATP
concentrations [Kron et al., 1992]. MYO19-3IQ protein was adhered to nitrocellulose-coated
slides via antibody interactions with either the antibody target site following the third IQ
motif, or the C-terminal 6×His tag. ATP-dependent movements of fluorescently-labeled
actin filaments were observed in all cases (Figure 5A). Velocities ranged from 144±3 nm/s
at 0.1mM ATP to 229±4 nm/s at 2mM ATP. Fitting the data to the equation of a hyberbola
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and assuming velocity in the absence of ATP was zero resulted in a Vmax of approximately
220 nm/s, a value similar to what was measured at 2mM ATP (Figure 5B).
Previously observed gain-of-function is dependent on motor activity
Ectopic expression of GFP-tagged, full length MYO19 in cultured A549 pulmonary
epithelial cells resulted in a gain-of-function where the entire mitochondrial network
displayed increased dynamics as measured by displacement index (DI) [Caviston et al.,
2011; Quintero et al., 2009]. With a DI of approximately 1, the mitochondrial network in
A549 cells under control conditions is not highly dynamic across the timescales observed in
this experiment [Quintero et al., 2009] (Supplemental Figure 4). We hypothesized that the
functional gain was mediated by MYO19 motor activity via its ATPase, and chose to test the
hypothesis using the same DI assay with a GFP-tagged MYO19 with impaired motor
activity. Mutation of G135 to R is hypothesized to disrupt ATP binding and result in a rigor-
like mutant [Bejsovec and Anderson, 1990; Lechler et al., 2000]. Similar to what had been
previously observed, ectopic expression of wild type, full length GFP-MYO19 resulted in an
increased DI when compared to cells expressing GFP-MYO19 tail, a construct lacking the
motor domain entirely. Expressed GFP-MYO19-G135R localized to mitochondria, but did
not result in the gain-of-function observed with the wild type protein, indicating a
requirement for a functional motor domain in the gain-of-function phenotype (Figure 5C).
Introduction of the G135R mutation into MYO19-1IQ resulted in a 1.5-fold reduction in
endogenous ATPase activity and a 3.3-fold reduction in actin-activated ATPase activity at
30μM F-actin (0.3±0.1 s-1), when compared to wild-type MYO19-1IQ (1.3±0.3 s-1), in vitro
(Supplemental Figure 5). Although not a complete elimination of ATPase activity, the
observations are consistent with a reduction in motor activity disrupting MYO19-induced
dynamics.
MYO19 in the context of the cell
Here we demonstrate that the motor domain of human MYO19 contains biochemical
properties predicted for a myosin. Human MYO19 constructs contain an actin-activated
ATPase with the ability to: bind actin in an ATP-dependent manner, bind a common myosin
light chain, and translocate actin filaments in vitro. Inactivating mutations result in
diminished ATPase activity and do not induce the gain-of-function observed with the wild-
type protein. Based on our analyses, class XIX myosins show sequence similarity to other
myosins that allow for comparison between myosin genes by both sequence alignment and
threading to crystal structures of well-characterized myosins. Comparisons based on these
similarities allowed for the identification of regions of “conserved difference” within class
XIX myosin orthologs that suggested differences in chemomechanical properties of
MYO19. These differences in key sequences essential for myosin function (such as the
nucleotide binding region, actin binding region, and lever arm) are not found in other
myosin classes. The chemomechanical properties of MYO19 are important determinants of
the class-specific functional differences related to the cellular roles of MYO19.
These data suggest that MYO19 could serve as a mitochondrial anchor under the proper
cellular conditions. It has been shown that growth factor-induced docking of mitochondria
may involve actin, as pharmacologic depletion of F-actin reduces accumulation of
mitochondria at sites of induced growth factor signaling [Chada and Hollenbeck, 2004]. In
Drosophila neuronal cells myosin V and VI have been reported to oppose long range MT
based movements and facilitate docking of the organelle [Pathak et al., 2010]. The kinetics
of the motor also support the possibility that a docking mechanism could ensure that
mitochondria stay bound in areas where the regional concentration of ADP is high or ATP is
low. The cosedimentation data indicate that under steady-state conditions, MYO19 contains
a high steady-state affinity for actin. In our assays, most of the MYO19 was actin-bound
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(cosedimentation assay) at actin concentrations that were sub-saturating in the steady-state
ATPase assay. The fact that Kactin < KATPase, suggests that the rate-limiting step occurs
when MYO19 is actin-bound [Howard, 2001]. For many high-duty ratio myosins, the
release of ADP from the nucleotide binding site of actin-bound myosin is the rate-limiting
step [De La Cruz and Ostap, 2004]. Therefore, under conditions where local ADP
concentrations were elevated, such a motor would likely remain actin-bound. As MYO19 is
linked to one of the major sources of cellular ATP (the mitochondrion), it is possible that
MYO19 may be serving as an inherent ATP sensor, anchoring the mitochondrion to actin
where local ADP concentrations are high, and moving mitochondria away from high local
ATP concentrations through motility (Figure 6).
Although evidence does not yet exist to indicate whether MYO19 functions as a monomer, it
could work in high densities to create an effective duty-ratio capable of producing directed
cargo transport. Myosin-I and most characterized myosin-II isoforms must work in
ensembles of many motors to generate movement along an actin filament as in vitro studies
show that sliding is a function of protein density [Finer et al., 1994; Harada et al., 1990;
Uyeda et al., 1990]. Thus, MYO19 might utilize this mechanism to “motor” when the
concentration of MYO19 on the mitochondria reaches a level capable of inducing
movement. However, MYO19 at high densities on the mitochondrial outer membrane could
interfere with motility. Previously we observed that ectopic expression of MYO19 leads to a
decreased velocity of mitochondria and a morphological change in which mitochondria have
a tadpole-like shape where the leading edge is wider than the trailing edge [Quintero et al.,
2009]. By increasing the motor density past some threshold level, it is possible that some
MYO19-actin interactions were inducing a drag-like force on the organelle, both slowing the
movements and altering the geometry of the organelle. Such an effect would be more
dramatic for a motor which spends a large fraction of its chemomechanical cycle in the
actin-bound states.
Taken together these data lead us to a model in which the local ratio of [ADP] to [ATP] is
among the factors that might regulate the function of MYO19, resulting in a system in which
the mitochondria can be effectively positioned in regions of the cell where they are most
needed. We cannot fail to recognize that there are also other motors present on mitochondria
that could impact the dynamic distribution of this organelle. Mechanisms coordinating the
activities of multiple motor species exist for other organelle systems and such regulatory
mechanisms remain to be characterized for mitochondria motors.
Materials and Methods
Sequence Analysis
We performed a sequence comparison to determine the sequence variability in the conserved
regions of the MYO19 motor with respect to the conserved regions of other myosins. The
core motor domain of Human MYO19 (corresponding to amino acids 37-750 of human
MYO19 [Quintero et al., 2009], NP_001157207, was directly aligned against the core motor
domain of five other myosins using ClustalX 2.1 (multiple alignment mode, default settings)
[Larkin et al. 2007]: rabbit MYH2 (skeletal) XP_002718996.1, chicken MYO5A
NP_990631.1, pig MYO6 NP_999186.1, cow MYO10 NP_776819.1, and human MYO1C
NP_001074248.1. These species were selected for alignment due to the availability of
biochemical data (reviewed in [El-Mezgueldi and Bagshaw, 2008]). Regions of the aligned
sequences were then selected for comparison based on the previously described variably
conserved regions [Cope et al., 1996], including conserved regions in the ATP binding
domain (P-loop, Loop 1, Switch I, Switch II) and the actin binding region (Loop-2, Loop-3,
Loop-4, HMC loop, the helix-loop-helix). These regions were evaluated based on length,
sequence, and net charge. To determine if the sequence changes observed in human MYO19
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as compared to the other 5 myosins were unique to MYO19, the sequences were compared
to the alignment of 143 myosin sequences by Cope et al. [Cope et al. 1996] and of 1984
sequences by Odronitz and Kollmar [Odronitz and Kollmar, 2007].
We identified the class-XIX specific amino acid differences by aligning the human MYO19
core motor domains with 41 other MYO19 orthologs obtained from the NCBI database, the
Ensembl Genome Browser, and supplementary data from Odronitz and Kollmar [Odronitz
and Kollmar, 2007] using ClustalX 2.1 multiple alignment mode with default settings.
Included sequences consisted of a combination of verified and predicted gene products.
Three of the identified MYO19 orthologs were excluded based on the incomplete nature of
the sequence (Supplemental Table I). A phylogenetic tree of all 45 sequences was generated
using the neighbor joining and bootstrap method (1000 replicates) in ClustalX2.1, and
drawn using FigTree v 1.3.1.
Computer modeling/threading
To determine a likely tertiary structure for MYO19, amino acids 1-827 of the human
MYO19 sequence were submitted to the Protein Homology/analogy Recognition Engine
(Phyre2) web server. Briefly, the engine uses homology identification and secondary
structure prediction to determine structural homologues by a profile-profile alignment
algorithm [Kelley and Sternberg, 2009]. High scoring alignments are then used to construct
a three-dimensional model of the submitted sequence.
Since the regions of myosins directly involved in the actin binding interface are not well
resolved in the structures generated via X-ray crystallography, but have been positioned
through a combination of modeling crystallography and cryo-electron microscopy [Holmes
and Geeves 2000; Holmes et al., 2004; Rayment et al., 1993], Phyre2 was also used to
predict the structure of the actin-binding interface of MYO19 by aligning the human
MYO19 sequence directly to the actomyosin structure by Lorenz and Holmes [Lorenz and
Holmes, 2010].
Expression Plasmids
Five expression plasmids were generated via PCR cloning, restriction digestion, and ligation
into expression plasmids, using the human MYO19 coding sequence as the template. A
construct consisting of an N-terminal FLAG tag and amino acids 2-848 consisting of the
motor domain and 3 IQ motifs, and a C-terminal 6×His tag (MYO19-3IQ) was generated in
the pFastbac plasmid by adding the restriction site for EcoRI at the 5′-end and the coding
sequence for 6×His and a restriction site for SalI at the 3′ end via PCR, and then inserting
the product into the vector via restriction digestion and ligation. The FLAG-tag was then
added at the N-terminus via PCR mutagenesis, removing the EcoRI restriction site in the
process. To generate a construct consisting of an N-terminal FLAG-tag, the motor domain,
and one IQ motif (amino acids 2-787), a stop codon was inserted following the codon for
amino acid 787 via PCR mutagenesis. peGFP-MYO19 and peGFP-MYO19 tail were
generated as previously described [Quintero et al., 2009]. peGFP-MYO19-G135R contains
an inactivating point-mutation in the motor domain thought to generate a motor with
impaired nucleotide binding ability [Bejsovec and Anderson, 1990; Lechler et al., 2000] and
was generated by PCR mutagenesis. A table of primers used in this study can be found in
Supplemental Table II.
Protein Purification
A construct of MYO19 1IQ and 3IQ was generated by inserting the above mentioned cDNA
clones into pFastbac (Invitrogen). Recombinant baculovirus were generated using standard
protocols and MYO19 proteins were purified from Sf9 cells as previously described [Dose
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et al. 2007; Dose et al. 2008]. Suspension cultures of Sf9 cells were infected with
baculovirus containing sequences encoding for expression of calmodulin and baculovirus
containing sequences encoding for expression of a MYO19 construct. Cells were allowed to
grow for 3-days at 28°C with shaking, and were then pelleted at 5000×g for 30 minutes. Cell
pellets were resuspended in lysis buffer (10mM Tris-HCl, 400mM KCl, 1mM EDTA, 1mM
EGTA, 2mM MgCl2, 2mM ATP, 2mM DTT, 0.01mg/ml aprotinin, 0.1mg/ml leupeptin,
1mM PMSF, 0.5% Igepal, 5% sucrose, pH 7.5) and lysed by homogenization in a Dounce
homogenizer with a Teflon pestle. Lysates were cleared by centrifugation at 180,000×g for 1
hour (4°C). Supernatants were run over FLAG affinity resin, washed in wash buffer (10mM
Tris-HCl, 200mM KCl, 1mM EDTA, 1mM EGTA, 2mM MgCl2, 2mM ATP, 2mM DTT,
0.01mg/ml aprotinin, 0.1mg/ml leupeptin, 1mM PMSF, 5μg/ml calmodulin, pH 7.5), and
then eluted by gravity flow in a small volume of wash buffer containing FLAG peptide
[Wang et al. 1998]. The elute was concentrated using at centricon spin concentrator, and
then dialyzed against KMg50DTT (50mM KCl, 10mM imidazole, 1mM EGTA, 1mM
MgCl2, 1mM DTT, pH 7.0). Calmodulin was expressed and purified in bacteria as described
[Putkey et al., 1985]. Actin was purified from acetone powder generated from rabbit skeletal
muscle myosin [Pardee and Spudich, 1982], and all experiments contained equimolar
phalloidin.
Steady State ATPase Assay
MYO19 ATPase activity in the presence of increasing actin concentration was determined
via the NADH-linked assay, as previously described [De La Cruz and Ostap, 2009; De La
Cruz et al., 2000]. The reaction mixture contained 0.1μM MYO19 protein in reaction buffer
(KMg50DTT, pH 7.0 supplemented with 0.2mM NADH, 10U/mL lactate dehydrogenase,
0.5U/mL phosphoenol pyruvate, 45U/mL pyruvate kinase). To determine actin activation,
reaction mixtures containing increasing concentrations of actin were mixed and placed on
ice. Prior to the start of the assay, 1mM ATP was added to the reaction mixture. The
absorbance at 340nm was observed for 2 minutes (25°C) using an Applied Photophysics SX.
18MV-R stopped-flow reaction analyzer. Absorbance traces were fit to the equation of a
line, and velocities (ATP·s-1) were determined from the calculated slope, MYO19
concentration, and extinction coefficient of NADH. Rates were corrected for the ATPase
activity of F-actin by subtracting the calculated velocity for the appropriate actin-only
control from the actoMYO19 samples. The turnover number (kcat) and Michaelis-Menten
constant with respect to [actin] (KATPase) were calculated by fitting the plot of reaction
velocity versus [Actin] to the equation of a hyberbola.
Cosedimentation Assay
To determine the fraction of MYO19 associated with actin under steady-state conditions,
actin cosedimentation assays were performed [De La Cruz and Ostap, 2009]. Increasing
concentrations of actin were incubated with 0.5μM MYO19 in KMg50DTT reaction buffer
without lactate dehydrogenase supplemented to 2mM MgCl2 and allowed to incubate on ice
for 10 minutes, then allowed to equilibrate to room temperature for 10 minutes. The tubes
were incubated at room temperature for 10 minutes following the addition of ATP to a final
concentration of 2mM. Samples were then centrifuged at 320,000×g for 15 minutes (25°C).
The supernatants were removed, and pellets resuspended in 8M urea. Pellet and supernatant
samples were separated by SDS-PAGE, stained with Coomassie blue, and the fraction of
MYO19 in the supernatant and pellet was calculated by densitometry analysis using ImageJ
[Abramoff et al., 2004]. For each experiment a “rigor” control at 5μM actin with no ATP
added was also run in parallel.
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Calculation of CaM/MYO19 ratio
The relative amount of calmodulin bound to MYO19 was calculated via densitometry of
samples from cosedimentation assays. The samples were prepared as described above, and
the density of the MYO19 and calmodulin bands were determined. To calculate the ratio of
CaM per MYO19, the measured density of the bands were divided by their molecular
weights to determine relative molar amounts, and then the relative molar amount of CaM
was divided by the relative molar amount of MYO19. The intensity of the calmodulin band
associated with the actin-bound MYO19-3IQ/CaM complex after actin co-sedimentation
was compared to a standard curve of calmodulin on the same SDS-PAGE gel to determine
the stoichiometry of the MYO19-3IQ/CaM complex.
In vitro motility Assay
The velocity of MYO193IQ-mediated actin movements was determined via the in vitro actin
gliding assay as described previously [Kron et al., 1992]. In a flow cell assembled from a
nitrocellulose-coated coverslip (22×22mm, #1.5), glass slide, and double-sided tape. The
flow cell was incubated with 0.12μg/ml anti-MYO19 antibody [Quintero et al., 2009] in
KMg50 for two minutes, washed twice with 1mg/ml bovine serum albumin in KMg50, and
then rinsed with KMg50. 0.25μM MYO19-3IQ in KMg50 was allowed to bind in the flow
cell for 2 minutes, and then washed with KMg50. 10nM Rhodamine-labeled f-actin was
added, followed by the addition of KMg50DTT activation buffer (KMg50DTT, pH7.0, 0.7%
methyl cellulose, 5μM CaM, 1mg/mL BSA, 3 mg/ml glucose, 2.5 mM phosphoenol
pyruvate, 20 units/ml pyruvate kinase, 0.1 mg/ml glucose oxidase, and 0.018 mg.ml
catalase). The flow cell was imaged via time-lapse microscopy using a Nikon TE2000-PFS
equipped with a 60×/1.4NA lens and a Coolsnap HQ2 cooled CCD camera controlled using
Nikon Elements 3.0. Velocity was calculated using the ImageJ plugin in, MtrackJ [Meijering
et al., 2012] as the change in distance divided by elapsed time.
Mammalian Cell Culture and transfection
Human pulmonary carcinoma cells, A549 [Lieber et al., 1976], were maintained in culture in
F12K medium supplemented with 10% fetal bovine serum, penicillin (50U/ml), and
streptomycin(50μg/ml), at 37°C in an atmosphere of 5% CO2, as described previously
[Quintero et al. 2009]. For expression of GFP-tagged constructs, cells were transfected using
Fugene HD transfection reagent according to the manufacturer's protocol. Briefly, 30,000
cells were plated into wells of a 6-well plate containing a 22×22mm #1.5 coverslip and
allowed to adhere overnight. Plasmid DNA/Fugene HD complexes were then added to each
well (1μg-2μg DNA per well) and allowed to incubate with the cells for 18-30 hours before
imaging.
Displacement Index Assay
Ectopic expression of full length GFP-MYO19 has been shown to lead to a gain-of-function
where the dynamics of the mitochondrial network are increased [Quintero et al. 2009]. The
displacement index for GFP-MYO19-G135R was measured and compared to that for GFP-
MYO19 tail and GFP-MYO19. Briefly, A549 cells expressing a GFP-MYO19 construct
were placed in a Rose chamber filled with OptiMem without phenol red containing
Penicillin and streptomycin and maintained at ∼32°C on the microscope stage. The cells
were imaged via time-lapse microscopy using a Nikon TE2000-PFS equipped with a 60×/
1.4NA lens and a Coolsnap HQ2 cooled CCD camera controlled using Nikon Elements 3.0.
Cells were imaged for 40 frames with a 5-second interval between frames. Metamorph 5.07
was used to calculate displacement index by applying a threshold to the image stacks that
defined the area containing mitochondria. The stack was maximum projected to determine
the total area which contained mitochondria at any point during the image acquisition.
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Displacement index was calculated by dividing the area calculated from the maximum
projection by the area containing mitochondria in the first frame. If the network was not
dynamic, then the DI would be close to 1. If the mitochondrial network displayed dynamics
over the course of the movie, then DI would be a value greater than 1.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Myosin XIX orthologs have been identified in many species and exhibit conserved
differences compared to other myosins
(A) An unrooted phylogenetic tree of 42 Myo19 orthologs from invertebrates (light green),
fish (dark green), amphibians (dark blue), reptiles (cyan), birds (purple), and mammals
(orange). Dots represent nodes validated by bootstrapping values of greater than 90%. (B)
Comparisons of key catalytic regions within the motor domain of human MYO19 and other
well-characterized myosins. Underlines indicate amino acids which are well-conserved
across MYO19 orthologs but represent unique sequence differences when compared to other
myosin classes. (C) Alignment of the converter domains of human MYO19 and other well-
characterized myosins indicates MYO19-specific sequence insertions within the converter
that do not correspond to the MYO6 “reverse gear” sequence insertion that reorients the
lever-arm.
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Figure 2. Alignment of the sequences involved in actin interactions suggests differences in actin
affinity
(A) The residues likely involved in acto-MYO19 interactions were determined by threading
the human MYO19 sequence to a model of actin-bound MYH2 [Lorenz and Holmes 2010]
using Phyre2 [Kelley and Sternberg 2009]. Residues at 8 out of 13 predicted electrostatic
interactions between MYH2 and the actin filament are conserved in MYO19, but there is
less conservation in the residues thought to make hydrogen bonds with actin. (B) Sequences
thought to be involved in actin/MYO19 interactions show some variations in overall charge
and amino acid makeup when compared to the corresponding sequences in other classified
myosins. The net charge of zero for loop 2 and the separation of lysine residues by a
negative charge could indicate an altered affinity for actin. However, the HCM loop carries
a much higher positive charge than for other myosins, ranging from +3 to +6 in MYO19
orthologs analyzed. Similarly, the helix-turn-helix for Myo19 carries no charge, but it is
negatively charged in other myosins (37/41 MYO19 orthologs contain a helix-turn-helix
with a charge of 0 or greater). Blue indicates + charge, red indicates - charge, and bold
indicates a perfectly conserved amino acid. The net charge for human MYO19 is indicated.
The number in parentheses is the median charge for the 41 orthologs analyzed. Amino acids
identified in [Lorenz and Holmes 2010] as forming electrostatic interactions with actin that
are shown on the model are also underlined in the sequences. Asterisks (*) indicate positions
which have a conserved residue, colons (:) indicate conservation between groups of strongly
similar properties, and periods (.) indicate conservation between groups of weakly similar
properties.
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Figure 3. Truncations of human MYO19 can be expressed and purified from an insect-cell
expression system
(A) FLAG-tagged MYO19-1IQ or MYO19-3IQ expressed in Sf9 cells can be affinity
purified to high purity as seen by Coomassie-stained SDS-PAGE. (B) Both crude lysates
and enriched fractions are reactive to antibodies against the FLAG-tag or MYO19, while
washes show little reactivity to the antibodies as visualized via western blot. (C) A
schematic representation of the domains included in the MYO19-1IQ and MYO19-3IQ
constructs.
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Figure 4. Steady-state enzymatic analysis of expressed MYO19 constructs indicate that it is an
actin-activated ATPase
(A) Steady-state ATPase assays indicate that the Myo19-1IQ ATPase is activated by
increasing actin concentration, a hallmark of myosin motors. Data are an average of 4-5
separate protein preparations. (B) Similar results were obtained with the Myo19-3IQ
construct. Data are an average of 3-4 separate protein preparations. (C)Mixing of 0.25μM
MantATP with 0.5μM Myo19-1IQ allows an estimate of vo ∼0.03 ATPs-1 by fitting the
fluorescence decay to a single exponential. (D)The affinity of Myo19-1IQ (0.5μM) for F-
actin in the presence of 2mM ATP was measured by cosedimentation assay and quantified
by densitometry of Coomassie-stained SDS-PAGE gels. Fraction bound is equal to the pellet
fraction divided by the sum of the supernatant and pellet fractions. The □ represents the
fraction of Myo19-1IQ bound to 5μM actin in the absence of ATP. Data are an average of 3
separate preparations. For A, B, and D, error bars represent SEM and errors for kinetic
measurements are standard error of the fit.
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Figure 5. MYO19 is capable of inducing actin-based movement
(A) Purified Myo19-3IQ was adhered to nitrocellulose-coated coverslips using a chicken
anti-human Myo19 antibody raised against the Myo19 tail. Rhodamine-phalloidin labeled
actin filaments were added to the chamber, followed by the appropriate concentration of
ATP. Time-lapse images were collected (1 frame/2 seconds, 2 minutes total time), and
velocities calculated from the time-lapse movies using MtrackJ. (B) Vmax was calculated by
fitting the data to a hyberbola and assuming velocity = 0 at 0mM ATP. Data are mean plus
or minus SEM, n0.1mMATP=39 filaments, n0.5mMATP=41 filaments, n2mMATP=45 filaments
across three different protein preps. Buffer conditions: 50mM KCl, 2mM MgCl2, 1mM
EGTA, 2mM DTT, 10mM imidazole, 0.7% methylcellulose, pH 7.0, 25°C. (C)Displacement
index (DI) of the mitochondrial network was measured in A549 cells expressing GFP-
MYO19 constructs. DI measures the dynamics of a set of objects by dividing the area
containing those objects at the start of a time-lapse (gray) by the maximum projection. The
maximum projection represents the space through which the objects moved during the time-
lapse (white including grey). Only ectopic expression of full-length GFP-MYO19 resulted in
an increased DI, while expression of GFP-MYO19G135R, which contains a motor-
inactivating mutation, and GFP-MYO19 tail did not. Time-lapses were 3 minutes and 20
seconds in duration (*p<0.05 compared to other conditions, Tukey analysis). Error bars
indicate SEM, nMYO19 = 28, ntail = 11, and nG135R = 8.Panels D-F are images representative
of the data. The cell periphery is outlined in white. Scale bar = 10 μm.
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Figure 6. Possible roles for MYO19 in mitochondrial dynamics
The presence of a high duty ratio myosin motor on mitochondria suggests a number of
possible roles for MYO19 in mitochondrial dynamics. Under conditions where local ATP
concentrations are high, the mitochondria might relocate via a MYO19-powered
mechanism. Upon reaching some critically low concentration of ATP, MYO19 may mediate
binding between mitochondria and local actin, placing the organelle where ATP demands
might be high. MYO19 may also serve to influence mitochondrial network shape and
geometry through linkages to the actin cytoskeleton.
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Table I
Well-conserved, charged amino acid residues located in the MYO19 actin-binding region
Human sequence number Human MYO19 sequence Motif Comment
315-317 EDE Loop 4 At least 2 negatively charged residues in all species except
Daphnia and cow
352 R HCM Loop 100% conserved across all aligned
359-361 QQQ HCM Loop At least 1 Q in all vertebrates. 2 Q in mammal, marsupial, bird,
amphibian, and reptile
364-365 RK HCM Loop R or K at 364 in bird, reptile, marsupial, and mammal except
rat, mouse, pig, cow, pika, and marmoset. R or K at 365 across
all aligned
489-490 EE Helix-turn-helix 100% conserved across all aligned
492 R Helix-turn-helix Conserved across all aligned except Daphnia
495 R Helix-turn-helix 100% conserved across all aligned
505 R Helix-turn-helix R or K in all aligned
507 R Helix-turn-helix 100% conserved in vertebrates
521 K Loop 3 100% conserved in vertebrates
524-525 RE Loop 3 R or K at 524 in vertebrates. E at 525 in mammal, marsupial,
and reptile, except Tasmanian devil
577-578 EK Loop 2 E at 577 in mammal and marsupial except hedgehog. K at 578
in in mammal and marsupial except hedgehog and dog.
581-582 EE Loop 2 Conserved in mammal and marsupial except dog, opossum,
and Tasmanian devil
588 R Loop 2 R or K in amphibian, bird, reptile, marsupial, and mammal
except turkey
MYO19 coding regions were trimmed down to the core motor domain, and then aligned using Clustal with the default settings [Larkin et al. 2007].
The loops involved in actin-binding were identified through a combination of alignment comparisons and comparison to threaded MYO19 models
(see Figure 2). Particular charged residues were well-conserved within the actin-binding region across MYO19 orthologs, as noted in the
“Comment” column.
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